GENE ONLINE|News &
Opinion
Blog

2022-04-27| Technology

Ultrasound Transducer for Combined Histotripsy Breaks Down Cancer Tumors

by GeneOnline
Share To
A team of engineers at the University of Michigan College of Engineering has developed a new non-invasive ultrasound technology called histotripsy, using ultrasound transducers that mechanically destroy liver tumors in mice through ultrasound waves with high precision. The study results showed that ultrasound therapy not only effectively killed 50-75% of cancer cells, but also activated the immune system in mice, reducing the risk of cancer recurrence or metastasis by about 81%.

It's free! Log in now to read

LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top